✦ LIBER ✦

Process transfer of DCVax-l to Europe and initiation of a phase III clinical trial in UK and Germany

✍ Scribed by Schmiedeknecht, G.; Kebbel, K.; Sonnabend, C.; Wagner, M.; Gryczka, M.; Stella, M.; Ganjei, K.; Bosch, M.; Powers, L.F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMC16 A COMPARISON OF CLINICAL TRIAL PAR

✍ SC Bolge; H Kannan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PIN6: ESTIMATED COSTS TO CONDUCT A PHASE

✍ M Dombeck; SL Dennett; CD Hamilton; L Bell 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Creative solutions to extraordinary chal

✍ Richa S Chandra, John Orazem, David Ubben, Stephan Duparc… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 205 KB

1137 A prospective, randomized, multicen

✍ Newling, D.W.W.; Mulder, D. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Early Drug Development (Strategies and R

✍ Cayen, Mitchell N. 📂 Article 📅 2010 🏛 John Wiley & Sons, Inc. ⚖ 564 KB

Therapeutic efficacy and safety of red b

✍ Richard J. Benjamin; Jeffrey McCullough; Paul D. Mintz; Edward Snyder; William D 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 109 KB